Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Marketable Securities : ¥664 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Chengdu Easton Biopharmaceuticals Co's Marketable Securities for the quarter that ended in Mar. 2024 was ¥664 Mil.

Chengdu Easton Biopharmaceuticals Co's annual Marketable Securities increased from Dec. 2021 (¥454 Mil) to Dec. 2022 (¥516 Mil) and increased from Dec. 2022 (¥516 Mil) to Dec. 2023 (¥742 Mil).

Chengdu Easton Biopharmaceuticals Co Marketable Securities Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co Marketable Securities Chart

Chengdu Easton Biopharmaceuticals Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

570.00

453.84

516.36

741.78

Chengdu Easton Biopharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															740.65	727.13	880.46	741.78	663.97

Chengdu Easton Biopharmaceuticals Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Chengdu Easton Biopharmaceuticals Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.eastonpharma.cn

Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines